Ketotifen Stulln 0,25 Mg/Ml Augentropfen Pharma Stulln

Ketotifen, the active ingredient in Ketotifen Stulln 0,25 Mg/Ml Augentropfen Pharma Stulln, is an antihistamine presented as a 0.25 mg/mL eye drops for ocular use. It treats allergic conjunctivitis and seasonal allergic eye disease in patients with allergic eye conditions.

GNH USA supplies Ketotifen Stulln 0,25 Mg/Ml Augentropfen Pharma Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketotifen is an antihistamine used to manage allergic eye disorders.

Allergic conjunctivitis: reduces ocular itching, redness and swelling. Seasonal allergic eye disease: alleviates symptoms during pollen season. Vernal keratoconjunctivitis: helps control chronic allergic inflammation of the conjunctiva.

Ketotifen eye drops may cause a range of ocular and systemic reactions.

Common Side Effects: - Burning or stinging sensation at the site of application. - Transient blurred vision after instillation. - Mild eye irritation or redness. - Headache. - Dryness of the ocular surface. - Temporary tearing.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling of the eyelids or face. - Corneal ulcer or epithelial defect. - Increased intra‑ocular pressure leading to glaucoma. - Persistent eye pain or photophobia. - Vision loss or significant visual disturbance. - Secondary infection of the eye.

Before using Ketotifen eye drops, consider the following safety measures.

Pregnancy: safety unknown; avoid unless benefit outweighs risk. Breastfeeding: safety unknown; use with caution. Contact lens wearers: remove lenses before instillation and wait before reinserting. Glaucoma patients: monitor intra‑ocular pressure as ketotifen may increase pressure. Known hypersensitivity: do not use if allergic to ketotifen or any excipients. Store at room temperature: keep in the original container, protect from light and moisture.

Ketotifen eye drops have limited systemic absorption, but certain ocular and systemic agents may interact.

Major Interactions (Avoid): - Concurrent use of other ocular antihistamines: may increase local irritation. - Topical ocular steroids: may mask signs of infection. - Preservative‑containing contact lens solutions: can exacerbate ocular discomfort.

Moderate Interactions (Monitor Closely): - Systemic antihistamines: may increase ocular dryness. - Beta‑blocker eye drops: monitor intra‑ocular pressure. - Corticosteroid eye drops: watch for additive pressure‑raising effects.